Skip to main content
SpringerLink
Log in

Thromboembolic events a risk in off-label use of rFVIIa

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Levi M, Levy JH, Andersen HF, Truloff D.Safety of recombinant activated factor VII in randomized clinical trials. New England Journal of Medicine 363: 1791-800, No. 19, 4 Nov 2010. Available from: URL: http://dx.doi.org/10.1056/nejmoa1006221

  2. Aledort LM.Off-label use of recombinant activated factor VII--safe or not safe? New England Journal of Medicine New England Journal of Medicine

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thromboembolic events a risk in off-label use of rFVIIa. React. Wkly. 1327, 2 (2010). https://doi.org/10.2165/00128415-201013270-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013270-00002

Keywords

Search

Navigation